Wermelinger, Felix

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2017 | 2016 | 2012 | 2011 | 2010 | 2007


Adler, Sabine; Sprecher, Marco; Wermelinger, Felix; Klink, Thorsten; Bonel, Harald Marcel; Villiger, Peter M (2017). Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis. Swiss medical weekly, 147, w14397. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14397


Villiger, Peter M; Adler, Sabine; Kuchen, Stefan; Wermelinger, Felix; Dan, Diana; Fiege, Veronika; Bütikofer, Lukas; Seitz, Michael; Reichenbach, Stephan (2016). Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet, 387(10031), pp. 1921-1927. Elsevier 10.1016/S0140-6736(16)00560-2


Rüst, Christoph Alexander; Knechtle, Beat; Rosemann, Thomas; Wermelinger, Felix (2012). Polymyalgia rheumatica in a married couple. International journal of general medicine, 5, pp. 711-714. Auckland (NZ): Dove Medical Press


Seitz, Michael; Reichenbach, Stephan; Bonel, Harald M; Adler, Sabine; Wermelinger, Felix; Villiger, Peter M (2011). Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss medical weekly, 141, w13156. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13156


Finckh, Axel; Dudler, Jean; Wermelinger, Felix; Ciurea, Adrian; Kyburz, Diego; Gabay, Cem; Bas, Sylvette; physicians of SCQM, (2010). Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. Joint bone spine, 77(4), pp. 313-8. Paris: Elsevier Masson SAS 10.1016/j.jbspin.2010.02.021


Fricker, M; Baumann, A; Wermelinger, F; Villiger, PM; Helbling, A (2007). A novel therapeutic option in Cogan dieseases? TNF-alpha blockers. Rheumatology international, -27(5), pp. 493-5. Berlin: Springer-Verlag 10.1007/s00296-006-0252-y

Provide Feedback